Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

Posted:
3
February 2021

Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London

Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London. As one of the largest independent clinical research organisations in the UK, Richmond Pharmacology has the expertise and equipment to adapt its London Bridge facility to administer vaccines for many residents in Southwark and the surrounding areas.  


Neil Coyle MP for Southwark and Old Borough outlines why this is important in his interview with BBC Politics London.


Richmond Pharmacology has been supporting the local community throughout the pandemic by providing rapid COVID tests to a local primary school, church, and synagogue. Assistance was also offered to staff at nearby businesses and hospitals when testing for the virus was not easily accessible.


Keith Berelowitz, Director of Operations at Richmond Pharmacology, said: “At what could be a pivotal moment during this pandemic, we must all do what we can to expedite the rollout of the vaccine in our local communities. We recognise that Richmond Pharmacology has the skills and facilities to support the Government in ensuring that the most vulnerable in our society are protected as soon as possible.”


Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

February 3, 2021
Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London
Read more

Richmond Pharmacology supports Codiak BioSciences in the development of a new medicine to help patients with cutaneous T cell lymphoma.

February 3, 2021
Richmond Pharmacology were pleased to provide our sponsor, Codiak BioSciences, with positive results of its exosome therapeutic exoIL-12.
Read more

Contributing to our community in 2020

December 17, 2020
Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.
Read more